Carlson Capital’s Covisint Corporation COVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-900,000
Closed -$2.21M 302
2017
Q2
$2.21M Buy
900,000
+506,725
+129% +$1.06M 0.03% 217
2017
Q1
$806K Hold
393,275
0.01% 243
2016
Q4
$747K Sell
393,275
-6,725
-2% -$14.5K 0.01% 263
2016
Q3
$872K Hold
400,000
0.01% 244
2016
Q2
$872K Hold
400,000
0.01% 274
2016
Q1
$800K Hold
400,000
0.01% 267
2015
Q4
$1M Hold
400,000
0.01% 283
2015
Q3
$860K Hold
400,000
0.01% 272
2015
Q2
$1.31M Sell
400,000
-20,733
-5% -$49.1K 0.01% 278
2015
Q1
$854K Hold
420,733
0.01% 286
2014
Q4
$1.11M Buy
420,733
+238,712
+131% +$684K 0.01% 297
2014
Q3
$755K Hold
182,021
0.01% 307
2014
Q2
$885K Buy
182,021
+6,821
+4% +$42.7K 0.01% 318
2014
Q1
$1.28M Buy
+175,200
New +$1.76M 0.01% 304

Carlson Capital's COVS Position: Q3 2017 in Review

Carlson Capital sold out of Covisint Corporation (COVS) in Q3 2017, closing a stake of 900,000 shares — an estimated $2.21M sold.

Carlson Capital first reported a position in COVS in Q1 2014 and held it in 14 quarters. The position peaked at $2.21M in Q2 2017. 0 funds tracked by Wall St. Rank hold COVS as of Q3 2017.

  • Carlson Capital reported no remaining Covisint Corporation position as of Q3 2017 after selling out during the quarter.
  • Carlson Capital sold 900,000 Covisint Corporation shares in Q3 2017, an estimated $2.21M.
  • Carlson Capital first reported a position in Covisint Corporation in Q1 2014 and held it in 14 quarters.
  • Carlson Capital's Covisint Corporation position peaked at $2.21M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2017.

Based on Carlson Capital's 13F filing for Q3 2017, filed 14 Nov 2017.